 David Karasik
Concepts (553)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 35 | 2024 | 243 | 6.610 |
Why?
| | Bone Density | 52 | 2024 | 489 | 5.930 |
Why?
| | Genome-Wide Association Study | 73 | 2025 | 1431 | 4.950 |
Why?
| | Zebrafish | 25 | 2025 | 499 | 4.460 |
Why?
| | Bone and Bones | 20 | 2024 | 317 | 4.230 |
Why?
| | Polymorphism, Single Nucleotide | 59 | 2024 | 2189 | 2.880 |
Why?
| | Sarcopenia | 6 | 2024 | 83 | 1.830 |
Why?
| | Genetic Predisposition to Disease | 26 | 2021 | 2427 | 1.810 |
Why?
| | Musculoskeletal System | 5 | 2021 | 48 | 1.680 |
Why?
| | Musculoskeletal Diseases | 4 | 2024 | 78 | 1.660 |
Why?
| | Phenotype | 28 | 2025 | 3196 | 1.650 |
Why?
| | Genetic Pleiotropy | 5 | 2019 | 31 | 1.430 |
Why?
| | Aging | 19 | 2023 | 1865 | 1.420 |
Why?
| | Inheritance Patterns | 6 | 2017 | 45 | 1.380 |
Why?
| | Anatomy | 2 | 2021 | 27 | 1.230 |
Why?
| | Body Composition | 4 | 2025 | 684 | 1.190 |
Why?
| | Lipid Metabolism | 4 | 2024 | 518 | 1.130 |
Why?
| | X-Ray Microtomography | 4 | 2024 | 94 | 1.130 |
Why?
| | Quantitative Trait Loci | 20 | 2021 | 380 | 1.110 |
Why?
| | Whole Genome Sequencing | 3 | 2025 | 160 | 1.090 |
Why?
| | Longevity | 10 | 2023 | 165 | 1.070 |
Why?
| | Genetic Loci | 12 | 2021 | 288 | 1.030 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 5 | 2022 | 8 | 1.020 |
Why?
| | Zebrafish Proteins | 4 | 2025 | 288 | 0.990 |
Why?
| | Genetic Variation | 8 | 2021 | 991 | 0.940 |
Why?
| | Genome, Human | 9 | 2024 | 425 | 0.910 |
Why?
| | Animals | 50 | 2025 | 36951 | 0.900 |
Why?
| | Hip | 6 | 2020 | 56 | 0.900 |
Why?
| | Quantitative Trait, Heritable | 5 | 2018 | 125 | 0.880 |
Why?
| | Fractures, Bone | 12 | 2024 | 380 | 0.850 |
Why?
| | Genomics | 10 | 2023 | 795 | 0.850 |
Why?
| | Osteoclasts | 2 | 2023 | 52 | 0.820 |
Why?
| | Musculoskeletal Physiological Phenomena | 2 | 2021 | 8 | 0.800 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4295 | 0.760 |
Why?
| | Oryzias | 1 | 2022 | 8 | 0.760 |
Why?
| | Humans | 124 | 2025 | 137782 | 0.750 |
Why?
| | Arginase | 1 | 2021 | 32 | 0.740 |
Why?
| | Bone Regeneration | 2 | 2019 | 26 | 0.730 |
Why?
| | Genetic Markers | 3 | 2021 | 344 | 0.730 |
Why?
| | Anatomists | 1 | 2021 | 1 | 0.730 |
Why?
| | Menarche | 6 | 2024 | 60 | 0.730 |
Why?
| | Urea | 1 | 2021 | 81 | 0.720 |
Why?
| | Muscles | 3 | 2022 | 326 | 0.710 |
Why?
| | Muscle, Skeletal | 7 | 2025 | 1724 | 0.680 |
Why?
| | Mobility Limitation | 1 | 2020 | 61 | 0.650 |
Why?
| | Bone Diseases, Metabolic | 1 | 2020 | 63 | 0.630 |
Why?
| | Body Fluid Compartments | 1 | 2019 | 6 | 0.610 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2607 | 0.600 |
Why?
| | Absorptiometry, Photon | 9 | 2022 | 259 | 0.590 |
Why?
| | Pelvic Bones | 2 | 2019 | 129 | 0.580 |
Why?
| | Models, Animal | 4 | 2024 | 384 | 0.550 |
Why?
| | Hypoxia | 2 | 2021 | 1112 | 0.550 |
Why?
| | Finite Element Analysis | 1 | 2017 | 75 | 0.540 |
Why?
| | Gene Frequency | 6 | 2024 | 521 | 0.540 |
Why?
| | Dissection | 1 | 2017 | 52 | 0.540 |
Why?
| | Telomere Shortening | 1 | 2016 | 20 | 0.520 |
Why?
| | Starvation | 1 | 2016 | 22 | 0.520 |
Why?
| | Female | 73 | 2025 | 73465 | 0.490 |
Why?
| | RNA, Long Noncoding | 3 | 2025 | 181 | 0.490 |
Why?
| | Gene-Environment Interaction | 2 | 2016 | 192 | 0.480 |
Why?
| | Peer Group | 1 | 2017 | 243 | 0.470 |
Why?
| | Teaching | 1 | 2017 | 224 | 0.460 |
Why?
| | Leukocytes | 1 | 2016 | 311 | 0.460 |
Why?
| | Oxidative Stress | 1 | 2021 | 1317 | 0.460 |
Why?
| | Adipose Tissue | 2 | 2019 | 635 | 0.460 |
Why?
| | Alkaline Phosphatase | 2 | 2018 | 148 | 0.460 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 188 | 0.460 |
Why?
| | Male | 59 | 2025 | 67906 | 0.440 |
Why?
| | Linkage Disequilibrium | 8 | 2020 | 268 | 0.430 |
Why?
| | Methyltransferases | 1 | 2014 | 78 | 0.420 |
Why?
| | Telomere | 1 | 2016 | 280 | 0.410 |
Why?
| | Cohort Studies | 22 | 2021 | 5750 | 0.410 |
Why?
| | Genetic Linkage | 4 | 2010 | 297 | 0.400 |
Why?
| | Bone Diseases | 3 | 2021 | 62 | 0.390 |
Why?
| | Aged | 33 | 2025 | 24001 | 0.390 |
Why?
| | Students, Medical | 1 | 2017 | 348 | 0.390 |
Why?
| | Physicians | 1 | 2021 | 914 | 0.380 |
Why?
| | Gene Regulatory Networks | 6 | 2021 | 305 | 0.380 |
Why?
| | Chromosome Mapping | 4 | 2010 | 523 | 0.380 |
Why?
| | Membrane Proteins | 6 | 2024 | 1164 | 0.380 |
Why?
| | GATA Transcription Factors | 1 | 2012 | 7 | 0.380 |
Why?
| | Femur | 6 | 2020 | 254 | 0.370 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2021 | 57 | 0.350 |
Why?
| | Middle Aged | 38 | 2025 | 33554 | 0.350 |
Why?
| | Reference Standards | 2 | 2024 | 186 | 0.340 |
Why?
| | Signal Transduction | 6 | 2024 | 5081 | 0.340 |
Why?
| | Lumbar Vertebrae | 7 | 2022 | 246 | 0.340 |
Why?
| | Phosphate Transport Proteins | 1 | 2010 | 2 | 0.340 |
Why?
| | Body Size | 3 | 2020 | 108 | 0.340 |
Why?
| | Calcification, Physiologic | 1 | 2010 | 32 | 0.330 |
Why?
| | Genotype | 17 | 2021 | 1917 | 0.330 |
Why?
| | Haplotypes | 4 | 2024 | 494 | 0.330 |
Why?
| | Pyrophosphatases | 1 | 2010 | 28 | 0.330 |
Why?
| | NF-kappa B | 1 | 2014 | 691 | 0.330 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2010 | 46 | 0.330 |
Why?
| | Spinal Fractures | 4 | 2016 | 73 | 0.330 |
Why?
| | Vitamin D | 5 | 2023 | 397 | 0.330 |
Why?
| | Mice | 18 | 2024 | 17794 | 0.330 |
Why?
| | Osteoporotic Fractures | 3 | 2018 | 60 | 0.320 |
Why?
| | Puberty | 2 | 2024 | 146 | 0.320 |
Why?
| | Spine | 4 | 2022 | 173 | 0.320 |
Why?
| | Femur Head | 2 | 2020 | 42 | 0.310 |
Why?
| | Metacarpal Bones | 1 | 2008 | 13 | 0.300 |
Why?
| | Durapatite | 2 | 2019 | 37 | 0.300 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1502 | 0.290 |
Why?
| | Hand Strength | 2 | 2021 | 123 | 0.290 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2024 | 2534 | 0.280 |
Why?
| | Hip Fractures | 2 | 2019 | 86 | 0.280 |
Why?
| | Femur Neck | 7 | 2020 | 61 | 0.280 |
Why?
| | Polymorphism, Genetic | 6 | 2018 | 660 | 0.280 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 660 | 0.270 |
Why?
| | Cardiovascular Diseases | 5 | 2018 | 2111 | 0.270 |
Why?
| | Leg | 1 | 2009 | 236 | 0.270 |
Why?
| | Aged, 80 and over | 15 | 2021 | 7637 | 0.270 |
Why?
| | Adult | 28 | 2025 | 38023 | 0.260 |
Why?
| | Larva | 2 | 2024 | 226 | 0.260 |
Why?
| | CRISPR-Cas Systems | 2 | 2024 | 125 | 0.250 |
Why?
| | Multifactorial Inheritance | 3 | 2024 | 174 | 0.250 |
Why?
| | Alleles | 10 | 2021 | 892 | 0.250 |
Why?
| | Risk Factors | 14 | 2025 | 10407 | 0.250 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2025 | 8 | 0.240 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2025 | 13 | 0.240 |
Why?
| | Transcription Factors | 2 | 2023 | 1719 | 0.240 |
Why?
| | Metabolic Syndrome | 2 | 2020 | 354 | 0.230 |
Why?
| | Israel | 3 | 2025 | 56 | 0.230 |
Why?
| | Proteostasis | 1 | 2025 | 29 | 0.230 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2017 | 382 | 0.230 |
Why?
| | Nanoparticles | 4 | 2019 | 482 | 0.230 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2024 | 7 | 0.230 |
Why?
| | Wnt Proteins | 4 | 2022 | 133 | 0.230 |
Why?
| | MyoD Protein | 1 | 2024 | 35 | 0.230 |
Why?
| | Genomic Imprinting | 3 | 2020 | 26 | 0.220 |
Why?
| | Evolution, Molecular | 1 | 2008 | 493 | 0.220 |
Why?
| | RNA-Binding Proteins | 3 | 2019 | 422 | 0.220 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 118 | 0.220 |
Why?
| | Menopause | 4 | 2021 | 320 | 0.220 |
Why?
| | Fishes | 1 | 2024 | 105 | 0.220 |
Why?
| | Calcium | 2 | 2024 | 1200 | 0.220 |
Why?
| | Mammals | 2 | 2023 | 283 | 0.220 |
Why?
| | Muscular Diseases | 1 | 2024 | 114 | 0.210 |
Why?
| | Muscle Development | 1 | 2024 | 111 | 0.210 |
Why?
| | Sarcomeres | 1 | 2024 | 96 | 0.210 |
Why?
| | Septins | 1 | 2024 | 43 | 0.210 |
Why?
| | Osteoblasts | 3 | 2021 | 126 | 0.210 |
Why?
| | Drosophila melanogaster | 1 | 2025 | 233 | 0.200 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2022 | 5 | 0.200 |
Why?
| | Perciformes | 1 | 2023 | 19 | 0.200 |
Why?
| | Cause of Death | 1 | 2005 | 436 | 0.200 |
Why?
| | Notochord | 1 | 2022 | 14 | 0.200 |
Why?
| | Craniosynostoses | 1 | 2023 | 57 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2024 | 455 | 0.190 |
Why?
| | Genetic Association Studies | 2 | 2016 | 377 | 0.190 |
Why?
| | Actins | 1 | 2024 | 416 | 0.190 |
Why?
| | Sex Characteristics | 5 | 2012 | 763 | 0.190 |
Why?
| | Extracellular Matrix Proteins | 3 | 2019 | 153 | 0.190 |
Why?
| | Versicans | 2 | 2019 | 5 | 0.190 |
Why?
| | ADAMTS Proteins | 2 | 2019 | 5 | 0.190 |
Why?
| | Vitamin D Deficiency | 2 | 2017 | 186 | 0.190 |
Why?
| | Ornithine Decarboxylase | 1 | 2021 | 10 | 0.190 |
Why?
| | Meta-Analysis as Topic | 4 | 2017 | 186 | 0.190 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2019 | 26 | 0.190 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2022 | 132 | 0.190 |
Why?
| | RNA, Messenger | 2 | 2021 | 2834 | 0.190 |
Why?
| | Validation Studies as Topic | 1 | 2021 | 22 | 0.190 |
Why?
| | Biology | 1 | 2023 | 88 | 0.190 |
Why?
| | DNA Repair | 2 | 2015 | 231 | 0.180 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2012 | 59 | 0.180 |
Why?
| | Europe | 6 | 2021 | 414 | 0.180 |
Why?
| | Osteoprotegerin | 2 | 2014 | 24 | 0.180 |
Why?
| | Systems Integration | 1 | 2021 | 37 | 0.180 |
Why?
| | Ovary | 2 | 2021 | 221 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 430 | 0.180 |
Why?
| | Methylmalonic Acid | 1 | 2021 | 65 | 0.180 |
Why?
| | Age Factors | 10 | 2018 | 3305 | 0.180 |
Why?
| | Gene Deletion | 2 | 2021 | 391 | 0.180 |
Why?
| | Vitamin B Complex | 1 | 2021 | 44 | 0.180 |
Why?
| | Mice, Knockout | 3 | 2024 | 3018 | 0.180 |
Why?
| | Brain | 3 | 2025 | 2677 | 0.170 |
Why?
| | Muscle Contraction | 1 | 2024 | 424 | 0.170 |
Why?
| | Polyamines | 1 | 2021 | 40 | 0.170 |
Why?
| | Mannose-Binding Lectin | 1 | 2020 | 23 | 0.170 |
Why?
| | Animals, Genetically Modified | 1 | 2021 | 240 | 0.170 |
Why?
| | Reproducibility of Results | 7 | 2019 | 3290 | 0.170 |
Why?
| | Carrier Proteins | 2 | 2017 | 771 | 0.170 |
Why?
| | Education | 1 | 2021 | 108 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 83 | 0.170 |
Why?
| | Osteoarthritis, Hip | 1 | 2020 | 45 | 0.170 |
Why?
| | Ligands | 1 | 2022 | 664 | 0.170 |
Why?
| | Muscle Weakness | 1 | 2021 | 88 | 0.160 |
Why?
| | Nerve Tissue Proteins | 1 | 2024 | 596 | 0.160 |
Why?
| | Regression Analysis | 4 | 2018 | 1024 | 0.160 |
Why?
| | Databases, Genetic | 3 | 2024 | 237 | 0.160 |
Why?
| | Nitrogen | 2 | 2018 | 168 | 0.160 |
Why?
| | Apolipoprotein E2 | 1 | 2019 | 3 | 0.160 |
Why?
| | Carbon | 2 | 2018 | 216 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 279 | 0.160 |
Why?
| | Nanocomposites | 1 | 2019 | 14 | 0.160 |
Why?
| | Genome | 1 | 2022 | 300 | 0.160 |
Why?
| | Jaw | 1 | 2019 | 26 | 0.160 |
Why?
| | Radiography | 5 | 2014 | 822 | 0.160 |
Why?
| | Apolipoprotein E4 | 1 | 2019 | 37 | 0.150 |
Why?
| | Homeodomain Proteins | 2 | 2015 | 506 | 0.150 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2019 | 19 | 0.150 |
Why?
| | Cortical Bone | 1 | 2019 | 18 | 0.150 |
Why?
| | Silver | 1 | 2019 | 38 | 0.150 |
Why?
| | Lipids | 1 | 2024 | 673 | 0.150 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2018 | 32 | 0.150 |
Why?
| | Acute Disease | 1 | 2021 | 1007 | 0.150 |
Why?
| | Adolescent | 13 | 2025 | 21574 | 0.150 |
Why?
| | Heat-Shock Proteins | 1 | 2019 | 143 | 0.150 |
Why?
| | Ribonucleoproteins | 2 | 2017 | 105 | 0.150 |
Why?
| | Electric Impedance | 1 | 2019 | 107 | 0.150 |
Why?
| | Jews | 1 | 2018 | 23 | 0.150 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2024 | 218 | 0.150 |
Why?
| | Wnt Signaling Pathway | 2 | 2021 | 192 | 0.150 |
Why?
| | Gold | 1 | 2019 | 118 | 0.150 |
Why?
| | Russia | 2 | 2016 | 11 | 0.140 |
Why?
| | Ultrasonography | 4 | 2014 | 763 | 0.140 |
Why?
| | Alveolar Bone Loss | 1 | 2017 | 9 | 0.140 |
Why?
| | Accidental Falls | 1 | 2020 | 196 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2021 | 282 | 0.140 |
Why?
| | Musculoskeletal Development | 1 | 2017 | 2 | 0.140 |
Why?
| | LDL-Receptor Related Proteins | 2 | 2008 | 7 | 0.140 |
Why?
| | DNA Methylation | 1 | 2023 | 643 | 0.140 |
Why?
| | Cholestanetriol 26-Monooxygenase | 1 | 2017 | 8 | 0.140 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 812 | 0.140 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2017 | 12 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2021 | 443 | 0.140 |
Why?
| | Exosomes | 1 | 2018 | 103 | 0.140 |
Why?
| | Muscle Strength | 2 | 2021 | 322 | 0.140 |
Why?
| | Chitosan | 1 | 2017 | 34 | 0.140 |
Why?
| | Drug Implants | 1 | 2017 | 82 | 0.130 |
Why?
| | Periodontitis | 1 | 2017 | 53 | 0.130 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 84 | 0.130 |
Why?
| | Sex Factors | 4 | 2007 | 2077 | 0.130 |
Why?
| | Strontium | 1 | 2016 | 14 | 0.130 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 512 | 0.130 |
Why?
| | Hydroxyapatites | 1 | 2016 | 16 | 0.130 |
Why?
| | Thinness | 1 | 2017 | 91 | 0.130 |
Why?
| | Receptor, EphB2 | 1 | 2016 | 4 | 0.130 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2016 | 6 | 0.130 |
Why?
| | Biomedical Research | 2 | 2021 | 700 | 0.130 |
Why?
| | Spinal Curvatures | 1 | 2016 | 4 | 0.130 |
Why?
| | Calcium-Binding Proteins | 3 | 2017 | 218 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2023 | 786 | 0.130 |
Why?
| | DNA Copy Number Variations | 3 | 2013 | 182 | 0.130 |
Why?
| | Societies, Medical | 1 | 2021 | 820 | 0.130 |
Why?
| | GTPase-Activating Proteins | 1 | 2016 | 83 | 0.130 |
Why?
| | Walking Speed | 1 | 2017 | 46 | 0.130 |
Why?
| | Hyperostosis | 1 | 2016 | 5 | 0.130 |
Why?
| | Rats | 2 | 2023 | 5648 | 0.130 |
Why?
| | Syndactyly | 1 | 2016 | 9 | 0.130 |
Why?
| | Cadaver | 1 | 2017 | 296 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2021 | 4193 | 0.130 |
Why?
| | Weight-Bearing | 1 | 2017 | 173 | 0.130 |
Why?
| | Osteogenesis Imperfecta | 1 | 2016 | 13 | 0.130 |
Why?
| | Diphosphonates | 1 | 2016 | 66 | 0.120 |
Why?
| | Biomarkers | 3 | 2016 | 4154 | 0.120 |
Why?
| | Chromosomes, Human, Pair 6 | 2 | 2013 | 52 | 0.120 |
Why?
| | Osteochondrodysplasias | 1 | 2016 | 18 | 0.120 |
Why?
| | Thoracic Vertebrae | 1 | 2016 | 77 | 0.120 |
Why?
| | Breast Neoplasms | 3 | 2018 | 2253 | 0.120 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2017 | 59 | 0.120 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2016 | 70 | 0.120 |
Why?
| | Simulation Training | 1 | 2017 | 107 | 0.120 |
Why?
| | Receptors, Neurokinin-3 | 1 | 2015 | 8 | 0.120 |
Why?
| | Laminin | 1 | 2015 | 72 | 0.120 |
Why?
| | Imidazoles | 1 | 2016 | 238 | 0.120 |
Why?
| | Organ Size | 3 | 2016 | 477 | 0.120 |
Why?
| | BRCA1 Protein | 1 | 2015 | 76 | 0.120 |
Why?
| | Program Development | 1 | 2017 | 368 | 0.120 |
Why?
| | Computational Biology | 3 | 2021 | 645 | 0.120 |
Why?
| | Educational Measurement | 2 | 2017 | 289 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2021 | 560 | 0.110 |
Why?
| | Crosses, Genetic | 2 | 2012 | 137 | 0.110 |
Why?
| | Hypothalamus | 1 | 2015 | 153 | 0.110 |
Why?
| | Immunoglobulins | 1 | 2015 | 171 | 0.110 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2014 | 21 | 0.110 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2014 | 55 | 0.110 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2014 | 46 | 0.110 |
Why?
| | Young Adult | 6 | 2025 | 13240 | 0.110 |
Why?
| | Proteins | 3 | 2015 | 1009 | 0.110 |
Why?
| | Apolipoproteins E | 1 | 2014 | 83 | 0.110 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2014 | 36 | 0.110 |
Why?
| | Linear Models | 1 | 2016 | 849 | 0.110 |
Why?
| | Massachusetts | 3 | 2012 | 172 | 0.110 |
Why?
| | Caffeine | 1 | 2014 | 68 | 0.110 |
Why?
| | Myoblasts | 1 | 2014 | 84 | 0.110 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 197 | 0.110 |
Why?
| | Gait | 1 | 2017 | 296 | 0.110 |
Why?
| | Metformin | 1 | 2017 | 331 | 0.110 |
Why?
| | Calcaneus | 1 | 2014 | 31 | 0.100 |
Why?
| | Cell Count | 1 | 2014 | 324 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 191 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.100 |
Why?
| | Eating | 1 | 2016 | 380 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 901 | 0.100 |
Why?
| | Mortality | 2 | 2014 | 363 | 0.100 |
Why?
| | Phosphoproteins | 2 | 2012 | 338 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 374 | 0.100 |
Why?
| | Integrin alpha1 | 1 | 2012 | 2 | 0.100 |
Why?
| | Premenopause | 1 | 2013 | 131 | 0.100 |
Why?
| | Autoantigens | 1 | 2015 | 430 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 539 | 0.100 |
Why?
| | Lod Score | 1 | 2012 | 67 | 0.090 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 26 | 0.090 |
Why?
| | Family | 1 | 2016 | 671 | 0.090 |
Why?
| | Dexamethasone | 1 | 2014 | 370 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.090 |
Why?
| | Multiple Sclerosis | 1 | 2017 | 455 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2013 | 145 | 0.090 |
Why?
| | Mendelian Randomization Analysis | 2 | 2022 | 50 | 0.090 |
Why?
| | Environment | 1 | 2013 | 358 | 0.090 |
Why?
| | Folic Acid | 2 | 2021 | 186 | 0.090 |
Why?
| | Principal Component Analysis | 1 | 2012 | 195 | 0.090 |
Why?
| | Cell Differentiation | 2 | 2021 | 1991 | 0.090 |
Why?
| | Immunity | 1 | 2012 | 143 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2012 | 140 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2011 | 183 | 0.090 |
Why?
| | Databases, Factual | 1 | 2016 | 1357 | 0.090 |
Why?
| | Curriculum | 1 | 2017 | 996 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2018 | 2475 | 0.080 |
Why?
| | Family Characteristics | 1 | 2012 | 191 | 0.080 |
Why?
| | Body Mass Index | 6 | 2017 | 2390 | 0.080 |
Why?
| | Nuclear Proteins | 2 | 2012 | 712 | 0.080 |
Why?
| | Pedigree | 3 | 2020 | 514 | 0.080 |
Why?
| | Child | 9 | 2024 | 21989 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2011 | 501 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2697 | 0.080 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2009 | 41 | 0.080 |
Why?
| | Biomechanical Phenomena | 2 | 2016 | 811 | 0.070 |
Why?
| | Diet | 3 | 2021 | 1279 | 0.070 |
Why?
| | Cell Line | 1 | 2014 | 2847 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 427 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2019 | 201 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2019 | 86 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2167 | 0.070 |
Why?
| | Metabolome | 1 | 2011 | 350 | 0.070 |
Why?
| | Testosterone | 1 | 2011 | 409 | 0.070 |
Why?
| | PPAR gamma | 1 | 2008 | 182 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1809 | 0.070 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2020 | 43 | 0.070 |
Why?
| | X-Ray Diffraction | 2 | 2017 | 104 | 0.070 |
Why?
| | Binding Sites | 1 | 2010 | 1303 | 0.070 |
Why?
| | Cancellous Bone | 2 | 2016 | 23 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 304 | 0.060 |
Why?
| | Adiposity | 1 | 2011 | 518 | 0.060 |
Why?
| | Molecular Sequence Annotation | 2 | 2016 | 99 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2020 | 180 | 0.060 |
Why?
| | Patient Selection | 1 | 2010 | 696 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2017 | 455 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2016 | 1251 | 0.060 |
Why?
| | Parents | 1 | 2014 | 1350 | 0.060 |
Why?
| | Age Determination by Skeleton | 1 | 2005 | 18 | 0.060 |
Why?
| | Life Expectancy | 1 | 2005 | 69 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5793 | 0.060 |
Why?
| | Puberty, Delayed | 1 | 2024 | 9 | 0.060 |
Why?
| | Puberty, Precocious | 1 | 2024 | 13 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2007 | 1316 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2017 | 175 | 0.050 |
Why?
| | Obesity | 3 | 2014 | 2993 | 0.050 |
Why?
| | Biological Evolution | 1 | 2008 | 475 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2016 | 61 | 0.050 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 36 | 0.050 |
Why?
| | Eicosanoids | 1 | 2024 | 62 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2025 | 347 | 0.050 |
Why?
| | Chromosomes, Human, X | 2 | 2015 | 74 | 0.050 |
Why?
| | Geriatric Assessment | 1 | 2005 | 224 | 0.050 |
Why?
| | Sphingolipids | 1 | 2024 | 77 | 0.050 |
Why?
| | Motor Activity | 1 | 2008 | 718 | 0.050 |
Why?
| | CpG Islands | 1 | 2023 | 157 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2024 | 220 | 0.050 |
Why?
| | Skull | 1 | 2023 | 139 | 0.050 |
Why?
| | Phospholipids | 1 | 2024 | 223 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2860 | 0.050 |
Why?
| | Neoplasms | 1 | 2017 | 2673 | 0.050 |
Why?
| | Survival Analysis | 1 | 2005 | 1325 | 0.050 |
Why?
| | Heterozygote | 2 | 2014 | 293 | 0.050 |
Why?
| | Morphogenesis | 1 | 2022 | 166 | 0.050 |
Why?
| | Vitamin B 6 | 1 | 2021 | 10 | 0.050 |
Why?
| | Age Distribution | 2 | 2016 | 392 | 0.050 |
Why?
| | Checkpoint Kinase 2 | 1 | 2021 | 29 | 0.050 |
Why?
| | Checkpoint Kinase 1 | 1 | 2021 | 30 | 0.050 |
Why?
| | Vitamins | 1 | 2023 | 185 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2023 | 247 | 0.050 |
Why?
| | Menopause, Premature | 1 | 2021 | 12 | 0.050 |
Why?
| | Reverse Genetics | 1 | 2021 | 3 | 0.050 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2021 | 3 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2021 | 50 | 0.040 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2021 | 38 | 0.040 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.040 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 31 | 0.040 |
Why?
| | Healthy Aging | 1 | 2021 | 35 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2003 | 436 | 0.040 |
Why?
| | Chromosomes, Human, Pair 11 | 2 | 2011 | 59 | 0.040 |
Why?
| | Adenylyl Cyclases | 1 | 2021 | 87 | 0.040 |
Why?
| | Vitamin B 12 | 1 | 2021 | 128 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 153 | 0.040 |
Why?
| | Body Height | 2 | 2011 | 199 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 160 | 0.040 |
Why?
| | Body Weight | 2 | 2017 | 985 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1946 | 0.040 |
Why?
| | Paternal Inheritance | 1 | 2020 | 3 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 215 | 0.040 |
Why?
| | Maternal Inheritance | 1 | 2020 | 16 | 0.040 |
Why?
| | Health Status | 1 | 2005 | 792 | 0.040 |
Why?
| | Liver | 2 | 2023 | 1943 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2020 | 102 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3569 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 318 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5764 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2004 | 778 | 0.040 |
Why?
| | Spectrophotometry | 1 | 2019 | 61 | 0.040 |
Why?
| | Prospective Studies | 3 | 2024 | 7623 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 516 | 0.040 |
Why?
| | Static Electricity | 1 | 2019 | 118 | 0.040 |
Why?
| | Adipocytes | 1 | 2021 | 222 | 0.040 |
Why?
| | Hydrogen Bonding | 1 | 2019 | 163 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2019 | 156 | 0.040 |
Why?
| | Fracture Healing | 1 | 2019 | 79 | 0.040 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2018 | 3 | 0.040 |
Why?
| | Lasers | 1 | 2019 | 130 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 15682 | 0.040 |
Why?
| | Smoking | 2 | 2023 | 1627 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2018 | 124 | 0.040 |
Why?
| | Heterografts | 1 | 2018 | 138 | 0.040 |
Why?
| | Nanostructures | 1 | 2019 | 107 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 652 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 623 | 0.040 |
Why?
| | Amidohydrolases | 1 | 2018 | 31 | 0.040 |
Why?
| | Protein Binding | 1 | 2024 | 2224 | 0.030 |
Why?
| | Porphyromonas gingivalis | 1 | 2017 | 23 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 476 | 0.030 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 5 | 0.030 |
Why?
| | Osteogenesis | 1 | 2019 | 188 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2017 | 27 | 0.030 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2017 | 19 | 0.030 |
Why?
| | Models, Genetic | 2 | 2015 | 600 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2836 | 0.030 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 10 | 0.030 |
Why?
| | Quantum Dots | 1 | 2017 | 37 | 0.030 |
Why?
| | Precision Medicine | 1 | 2021 | 433 | 0.030 |
Why?
| | Drug Liberation | 1 | 2016 | 35 | 0.030 |
Why?
| | Epidemiologic Studies | 1 | 2016 | 72 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2019 | 396 | 0.030 |
Why?
| | Stem Cells | 1 | 2021 | 594 | 0.030 |
Why?
| | Surface Properties | 1 | 2017 | 413 | 0.030 |
Why?
| | Adsorption | 1 | 2016 | 149 | 0.030 |
Why?
| | Kyphosis | 1 | 2016 | 39 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2017 | 123 | 0.030 |
Why?
| | Bone Remodeling | 1 | 2016 | 75 | 0.030 |
Why?
| | China | 1 | 2016 | 217 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 138 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 180 | 0.030 |
Why?
| | Breeding | 1 | 2016 | 64 | 0.030 |
Why?
| | Animal Feed | 1 | 2016 | 53 | 0.030 |
Why?
| | Materials Testing | 1 | 2017 | 356 | 0.030 |
Why?
| | Penetrance | 1 | 2015 | 28 | 0.030 |
Why?
| | Genes, X-Linked | 1 | 2015 | 18 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2015 | 44 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2019 | 423 | 0.030 |
Why?
| | Exercise | 1 | 2006 | 2061 | 0.030 |
Why?
| | Amides | 1 | 2015 | 93 | 0.030 |
Why?
| | Receptors, Kainic Acid | 1 | 2014 | 10 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1111 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 92 | 0.030 |
Why?
| | Forkhead Box Protein O3 | 1 | 2014 | 17 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11105 | 0.030 |
Why?
| | Receptors, GABA-B | 1 | 2014 | 11 | 0.030 |
Why?
| | Receptors, Retinoic Acid | 1 | 2014 | 43 | 0.030 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2014 | 14 | 0.030 |
Why?
| | Exome | 1 | 2015 | 231 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 967 | 0.030 |
Why?
| | Chromosome Breakpoints | 1 | 2013 | 8 | 0.030 |
Why?
| | Rural Population | 1 | 2018 | 567 | 0.030 |
Why?
| | Netherlands | 1 | 2014 | 88 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2012 | 1775 | 0.030 |
Why?
| | Reproduction | 1 | 2015 | 204 | 0.030 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 460 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1509 | 0.030 |
Why?
| | RNA Interference | 1 | 2015 | 469 | 0.030 |
Why?
| | Markov Chains | 1 | 2013 | 126 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2015 | 341 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2014 | 181 | 0.030 |
Why?
| | Cattle | 1 | 2016 | 985 | 0.030 |
Why?
| | Gene Dosage | 1 | 2013 | 140 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2014 | 197 | 0.020 |
Why?
| | Biopsy | 1 | 2016 | 1130 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 399 | 0.020 |
Why?
| | Spectrin | 1 | 2012 | 14 | 0.020 |
Why?
| | Endonucleases | 1 | 2012 | 32 | 0.020 |
Why?
| | Genes | 1 | 2012 | 230 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2012 | 8 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 443 | 0.020 |
Why?
| | Perilipin-4 | 1 | 2011 | 1 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1502 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2012 | 59 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2011 | 17 | 0.020 |
Why?
| | DNA Repair Enzymes | 1 | 2012 | 28 | 0.020 |
Why?
| | Exodeoxyribonucleases | 1 | 2012 | 22 | 0.020 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2012 | 44 | 0.020 |
Why?
| | DNA Primase | 1 | 2012 | 47 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 133 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1266 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 617 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2011 | 49 | 0.020 |
Why?
| | Subcutaneous Fat | 1 | 2011 | 81 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 57 | 0.020 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2010 | 30 | 0.020 |
Why?
| | DNA Helicases | 1 | 2012 | 145 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2010 | 27 | 0.020 |
Why?
| | Jagged-1 Protein | 1 | 2010 | 23 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 342 | 0.020 |
Why?
| | Homozygote | 1 | 2010 | 203 | 0.020 |
Why?
| | Immunoassay | 1 | 2010 | 115 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 86 | 0.020 |
Why?
| | International Cooperation | 1 | 2010 | 198 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2015 | 922 | 0.020 |
Why?
| | Adiponectin | 1 | 2011 | 244 | 0.020 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2009 | 36 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2010 | 329 | 0.020 |
Why?
| | Sexual Maturation | 1 | 2009 | 55 | 0.020 |
Why?
| | Canada | 1 | 2010 | 418 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1704 | 0.020 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2008 | 4 | 0.020 |
Why?
| | RANK Ligand | 1 | 2008 | 29 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 269 | 0.020 |
Why?
| | Lung | 1 | 2021 | 4060 | 0.020 |
Why?
| | Seasons | 1 | 2010 | 547 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1070 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6084 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2010 | 561 | 0.020 |
Why?
| | Psychiatric Nursing | 1 | 1985 | 12 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2734 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2010 | 1457 | 0.010 |
Why?
| | Calcium, Dietary | 1 | 2004 | 57 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9482 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2003 | 40 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1063 | 0.010 |
Why?
| | Bone Resorption | 1 | 2004 | 86 | 0.010 |
Why?
| | Homocysteine | 1 | 2003 | 156 | 0.010 |
Why?
| | Turkmenistan | 1 | 2002 | 1 | 0.010 |
Why?
| | Blood Glucose | 1 | 2012 | 2190 | 0.010 |
Why?
| | Postmenopause | 1 | 2004 | 366 | 0.010 |
Why?
| | Insulin | 1 | 2012 | 2411 | 0.010 |
Why?
| | Fingers | 1 | 2002 | 88 | 0.010 |
Why?
| | Life Style | 1 | 2004 | 491 | 0.010 |
Why?
| | Estrogens | 1 | 2004 | 367 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2010 | 5136 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6834 | 0.010 |
Why?
| | United States | 1 | 2010 | 14870 | 0.010 |
Why?
| | Counseling | 1 | 1985 | 391 | 0.000 |
Why?
|
|
Karasik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|